Want to see WGS full AI Analyst Report?
Total Valuation
GeneDx Holdings has a market cap or net worth of $2.60B. The enterprise value is $2.07K.
Market Cap$2.60B
Enterprise Value$2.07K
Share Statistics
GeneDx Holdings has 29,822,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding29,822,540
Owned by Insiders46.37%
Owned by Institutions17.60%
Financial Efficiency
GeneDx Holdings’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -2.50%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.04
Return on Invested Capital (ROIC)-2.50%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee328.88K
Profits Per Employee-16.17K
Employee Count1,300
Asset Turnover0.75
Inventory Turnover9.27
Valuation Ratios
The current PE Ratio of GeneDx Holdings is ―. GeneDx Holdings’s PEG ratio is 2.86.
PE Ratio―
PS Ratio8.18
PB Ratio11.35
Price to Fair Value11.35
Price to FCF245.23
Price to Operating Cash Flow-53.10
PEG Ratio2.86
Income Statement
In the last 12 months, GeneDx Holdings had revenue of 427.54M and earned -21.02M in profits. Earnings per share was -0.73.
Revenue427.54M
Gross Profit298.17M
Operating Income-11.80M
Pretax Income-21.14M
Net Income-21.02M
EBITDA6.63M
Earnings Per Share (EPS)-0.73
Cash Flow
In the last 12 months, operating cash flow was -48.71M and capital expenditures -27.09M, giving a free cash flow of -75.80M billion.
Operating Cash Flow-48.71M
Free Cash Flow-75.80M
Free Cash Flow per Share-2.54
Dividends & Yields
GeneDx Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-28.56%
50-Day Moving Average67.77
200-Day Moving Average87.28
Relative Strength Index (RSI)70.88
Average Volume (3m)792.87K
Important Dates
GeneDx Holdings upcoming earnings date is Nov 3, 2026, After Close (Confirmed).
Last Earnings DateAug 3, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
GeneDx Holdings as a current ratio of 2.46, with Debt / Equity ratio of 68.55%
Current Ratio2.46
Quick Ratio2.34
Debt to Market Cap0.03
Net Debt to EBITDA7.09
Interest Coverage Ratio-4.65
Taxes
In the past 12 months, GeneDx Holdings has paid -116.00K in taxes.
Income Tax-116.00K
Effective Tax Rate<0.01
Enterprise Valuation
GeneDx Holdings EV to EBITDA ratio is 534.93, with an EV/FCF ratio of 248.52.
EV to Sales8.29
EV to EBITDA534.93
EV to Free Cash Flow248.52
EV to Operating Cash Flow106.51
Balance Sheet
GeneDx Holdings has $132.55M in cash and marketable securities with $167.40M in debt, giving a net cash position of -$34.85M billion.
Cash & Marketable Securities$132.55M
Total Debt$167.40M
Net Cash-$34.85M
Net Cash Per Share-$1.17
Tangible Book Value Per Share$4.69
Margins
Gross margin is 68.20%, with operating margin of -2.76%, and net profit margin of -4.92%.
Gross Margin68.20%
Operating Margin-2.76%
Pretax Margin-4.94%
Net Profit Margin-4.92%
EBITDA Margin1.55%
EBIT Margin-4.35%
Analyst Forecast
The average price target for GeneDx Holdings is $85.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$85.00
Price Target Upside43.82% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast25.42%
EPS Growth Forecast-10900.00%